musculoskeletal system knh 413. skeletal system cartilage, ligaments, tendons, bones metabolically...

73
Musculoskeletal System KNH 413

Upload: steven-tyler

Post on 13-Jan-2016

218 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Musculoskeletal System

KNH 413

Page 2: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Cartilage, ligaments, tendons, bones

Metabolically active cells and tissue

Continual state of change

Page 3: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Cartilage – flexible yet firm connective tissue consisting of cells and collagen fibersChondroblasts/chondrocytes – cellsCollagen – fibrous protein, most common protein in

the bodyChondroitin sulphate – most common polysaccharide

of cartilage

Page 4: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Bone – osseous tissueOrganic – mineralized or calcified by inorganic

component; flexibility Inorganic - hydroxyapatite; stiffness, weight bearingReady source of calcium and phosphorus for

extracellular fluids Hydroxyapaptite (99%) Readily available pool (1%)

Page 5: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

BoneAbnormalities in serum calcium critical

Hypocalcemia – excessive excitability of the nervous system, tetany , respiratory arrest, convulsions

Hypercalcemia – fatigue, depression, metal confusion, anorexia, nausea, vomiting, constipation, hypercalciuria

Page 6: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Cells of Osseous TissueOsteogenic cells – stem cells that differentiate into

osteoblastsOsteoblasts - bone-building cellsOsteocytes – mature osteoblasts, majority of cells in

boneOsteoclasts – bone-removing cells that secrete HCl;

bone resorption

Page 7: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Skeletal growth and developmentContinual state of change; linear and circumferential

growth, and in response to changes in forces applied to them - remodeling

Osteoclasts remove bone from low-stress areas, osteoblasts lay down new bone in high-stress areas

Page 8: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Cortical boneDense, outer surface of most bones, shafts of

long bones, and caps over end of long bones75% of skeletal weight

Trabecular boneLoosely organized with a sponge-like

appearance; lattice-like pattern“Ends” of long bones, primary bone of

vertebrae, pelvis, sternum, scapula25% of skeletal weight

© 2007 Thomson - Wadsworth

Page 9: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 10: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 11: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Hormonal control of bone metabolismCalcium and phosphorus homeostasis

Cortisol, growth hormone, thyroid hormones Primary regulators: parathyroid hormone (PTH),

calcitonin, vitamin D

Page 12: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

PTH – increases blood calcium when low Increase in osteoclasts and bone resorption Inhibition of collagen synthesis and bone depositionCalcium resorption by kidneysFinal step in vitamin D synthesis, enabling intestinal

absorption of calcium

Page 13: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Calcitonin – decreases blood calcium when high Inhibits activity of osteoclastsStimulates osteoblastsReduces renal reabsorption of calcium and

phosphate

Page 14: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Vitamin D – increases blood concentrations of calcium and phosphorusPromotes their absorption in GIPromotes reabsorption by kidneysStimulates osteoclast formation and release of

calcium and phosphorus from bone

Page 15: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Skeletal System

Vitamin D –

Ergocalciferol - dietaryCholecalciferol – dietary,

exposure to sunlightBoth biologically inactive until

modified by liver and kidney to 1,25-dihydroxyvitamin D

Page 16: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 17: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoporosis

Decreased bone mineral and organic matrix which weakens bones, making them more susceptible to fracture and pain

Bone strength reflects:Bone densityBone quality

Page 18: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - WadsworthHealthy (L) and osteoporotic (R) trabecular bone

Page 19: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisDiagnosis

Measures of bone mineral density (BMD)DXA – dual-energy x-ray absorptiometry “T-score” – comparing patient’s BMD to healthy young

reference populationBMD assessed at hip and lumbar spineSee WHO criteria

Page 20: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

DEXA scan of the left hip

Page 21: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change
Page 22: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoporosis

Diagnosis

Others:Quantitative ultrasound of the heel used in

conjunction with risk assessment – useful for screening

Osteopenia – bone mineral density is low but not low enough to be classified as osteoporosis, although fracture risk is increased

Page 23: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoporosis

BMD increases rapidly during growth spurt (ages 11-14 y)

Maximum density reached in late 20s or 30s

Females lose BMD at faster rate than men

Rate of loss increases during menopause

Page 24: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoporosis

FracturesMost common sites: hip, spine, wristKyphosis – unnatural curvature of back, and loss of

height d/t compression fractures of spineHip fractures have severe impact on morbidity and

mortality 20% die within first year, 20% end up in nursing homes

Page 25: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoporosis

EtiologyPrimary – disease of elderly, cumulative impact of

bone mineral loss and deterioration of bone with age; “age-related,” “postmenopausal”

Secondary - disease and drug associated 2/3 of cases in men

Page 26: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 27: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change
Page 28: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoporosis

Risk factors

Genetic susceptibilityFamily hxFemale sexCaucasian racePremenopausal amenorrheaPhysical inactivityLow calcium and vitamin D intakes

Page 29: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 30: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoporosis

Prevention strategiesRisk reduction in adolescence and early adulthoodAdequate calcium and vitamin D intakeWeight-bearing exerciseFall preventionSmoking cessationAvoidance of excessive alcohol intake

Page 31: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 32: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoporosis

Calcium Maintenance of serum calcium levels to

combat bone resorptionAchieve peak bone mass and minimize bone

mineral lossLower intakes of animal protein, sodium,

caffeineIncreased consumption of fruits, vegetables,

legumes, whole grainsMore physical activitySun exposure

Page 33: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisCalcium

Consume calcium-rich foodsCalcium-fortified foodsCalcium supplements

Calcium carbonate – least expensive, taken with meals, not at the same time as iron

Calcium citrate – taken any time Calcium with vitamin D Avoid dolomite and bonemeal – lead contamination Divided doses to improve absorption

Page 34: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 35: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisVitamin D

Overt deficiency – rickets in children, osteomalacia in adults

Insufficiency found in dark-skinned, older, in northern latitudes (above 40 degree N)

Supplementation with vitamin D and calciumFortified dairy products Exposure to adequate sunlight

Page 36: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change
Page 37: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisPhysical activity

BMD increases with weight-bearing or impact-type activity

Very high levels can be detrimental if oligomenorrhea or amenorrhea present

Page 38: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisCigarette smoking

Lower BMD, increased bone mineral loss, increased risk of fractures

Nicotine and cadmium toxic to osteoblastsReduced intestinal calcium absorptionLower intakes of vitamin D, and lower serum vitamin

D

Page 39: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisAlcohol

Decreased BMD, reduced bone formation, increased risk of fractures

Increased calcium and magnesium lossesAdversely impacts vitamin D and overall nutritional

status Increased risk of falls

Page 40: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisPhosphorus – essential for bone formation

Carbonated soft-drinks have negligible effect on calcium excretion

High protein or sodium - increase urinary calcium losses

Potassium, magnesium, fruits, vegetables associated with higher BMD

Page 41: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisMedical management

Risk factor modificationDietary treatmentDrug therapy

Page 42: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 43: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

OsteoporosisPharmacologic prevention and treatment

Estrogens/ hormone therapySelective estrogen receptor modulators (SERMs)BisphosphonatesTeriparatide (synthetic PTH)Drug-nutrient interactions

Page 44: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Paget Disease

Localized, progressive, crippling disorder of bone remodeling d/t overactive osteoclasts and bone resorption followed by rapid formation of new bone which is structurally inferior

Bowing, deformity, fracture, poor healing

Upper femur, pelvis, vertebral bodies, skull, tibia

Genetic and viral factors

Adequate intake of vitamin D and calcium important

Page 45: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Rickets Inadequate maturation and

mineralization of bone in children

d/t vitamin D deficiency

Risk factors – Table 27.10

Symptoms: lethargy, weakness, growth stunting, enlargement of ends of long bones and ribs, abnormally shaped thorax, bowing of legs

Page 46: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change
Page 47: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Rickets

PreventionExclusively breast fed infants should receive

supplement of 200 IU vitamin DFortified infant formulas

If receiving less than 500 mL/day, should be given multivitamin supplement

After 1 year – vitamin D-fortified cow’s milk

Page 48: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Rickets

TreatmentBalanced, age-appropriate dietAdequate vitamin D, calcium, phosphorus

Page 49: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteomalacia

Organic matrix of bones inadequately mineralized in adults

Muscular weakness, bone pain, deformities of ribs, pelvis, legs

d/t vitamin D deficiency, impaired D action, calcium deficiency, hypophosphatemia

Page 50: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteomalacia

TreatmentAddress underlying causeMultivitamin supplementationCalcium supplementationPharmacological doses of vitamin D

Page 51: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Arthritic Conditions

Affect joints, tissues surrounding joints, and connective tissues

Osteoarthritis, rheumatoid arthritis, gout (affecting all ages)

Risk factors - modifiable:Overweight Joint injuries Infections

Page 52: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Arthritic Conditions

Risk factors - nonmodifiable:Female sex – 60% of casesAgeFamily hx

Page 53: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoarthritis

Most common, leading cause of physical disability

Disease process involving all structures of the jointLoss of load-bearing articular cartilageInflammationJoint pain, stiffness, limited movement,

wasting of periarticular muscles, joint instability and deformity

Page 54: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change
Page 55: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoarthritis

Major risk factorsAgeFemale sexFamily hxMajor trauma to joint or soft tissueRepetitive joint stress related to occupation Obesity

Page 56: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoarthritis

TreatmentReduce joint inflammation & pain, maintain mobility,

minimize disability Improve body postureProper footwearWeight reductionPeriodic rest of affected jointHeatPhysical activity/ therapeutic exercise

Page 57: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Osteoarthritis

TreatmentDrug therapy – pain relief

NSAIDs Glucosamine and chondroitin

Page 58: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Rheumatoid Arthritis

Chronic inflammatory disease; synovial membrane becomes inflamed resulting in swelling, stiffness, pain, limited range of motion, joint deformity, disability

Characterized by periods of exacerbation and remission

Autoimmune response

Page 59: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Rheumatoid Arthritis

Inflammation of joints of hands, wrists, knees, & feet results in warmth, redness, swelling, stiffness, and pain

Inflammation results in thickening of synovial membrane known as pannus – see Fig. 27.10

Enzymes from pannus digest adjacent bone and cartilage

Page 60: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change
Page 61: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Rheumatoid Arthritis

TreatmentReduce pain and inflammation, protect joint,

maintain function, control systemic infectionsPharmacological agents: NSAIDs, glucocorticoids,

immunosuppressives, DMARDs

Page 62: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Rheumatoid Arthritis

Diet Increase consumption of fruits and vegetables/

antioxidants Include sources of EPA and DHA (fatty acids)Fish oil supplementationExclusion of red meats, dairy, cereals, wheat glutenEvaluate and test for food allergy

Page 63: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Gout

Inflammatory disease resulting in swelling, redness, heat, pain, and stiffness in affected joint

d/t elevated serum concentrations of uric acid, formation of uric acid crystalsEnd product of purine (adenine and guanine)

metabolism

Page 64: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

Gout

Hyperuricemia results from overproduction of uric acid, inadequate elimination by the kidneys, or combination

Most painful arthritic condition

Risk factors: genetics, male sex, older age, overweight, excessive alcohol consumption, eating foods rich in purines, exposure to lead, certain drugs

Page 65: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

GoutMost commonly affects great toe, instep, ankles,

heels, knees, wrists, elbows, fingers

Rapid occurrence

Sudden severe pain; swelling; shiny, red skin around joint; extreme tenderness

Typically resolves 5-10 days, may reoccur

Page 66: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

GoutAcute attack may be precipitated by:

Excessive exerciseCertain medications: aspirin, diuretics, nicotinic acid,

cyclosporine, levodopaPurine-rich foods Excessive alcohol consumptionCrash dieting

Page 67: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 68: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

GoutTreatment:

NSAIDs, glucocorticoids, colchicineTreat uricemiaLifestyle modifications

Page 69: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

FibromyalgiaChronic musculoskeletal disorder characterized by

widespread muscle pain, joint stiffness, disturbed sleep, fatigue, headache, cognitive and memory problems, paresthesias, & tender points

Not crippling, deforming, or disabling

Etiology unknown

Page 70: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

FibromyalgiaDg by ruling out other potential causes of

symptomsHx of pain that is widespread for at least 3 monthsExcessive tenderness or pain with pressure to at least

11 of 18 tender points

Page 71: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

© 2007 Thomson - Wadsworth

Page 72: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

FibromyalgiaTreatment

Improve sleep, treat depression, anxiety and pain, improve ability to relax

Antidepressants, counselingRegular physical activityCognitive behavioral therapy Intensive patient education

Page 73: Musculoskeletal System KNH 413. Skeletal System Cartilage, ligaments, tendons, bones Metabolically active cells and tissue Continual state of change

FibromyalgiaDiet

Avoidance of certain foods has worked for someLow-sodium, uncooked vegan diet has shown promise ? MSG avoidanceLack of sound scientific evidence at this time